RespireRx Pharmaceuticals Inc (RSPI)

[Aiming4]

A couple of quick COR thoughts...

Who knows if CEPH will or won't be a formidable competitor for COR, but with the size of the markets for ADHD etc... there will be room for any medicine that works and doesn't have bad side effects.

Besides that, concerns about competition are in the distant future right now... the next important event for COR is coming up with the ADHD results. There is all kinds of clinical evidence showing that Ampakines have an effect on memory and cognition, so I expect the 3 upcoming trials to all show evidence of a beneficial effect as well.

The 2 big problems in past trials, namely a weak Ampakine that couldn't be dosed high enough, are both more than dealt with in the current trials. CX-717 is a much more potent Ampakine, and the upper doses being tested will be well more than adequate to show enough of an effect to get one of the BPs to sign a deal.

I'd never try to talk anyone into buying COR, but I think it is a very compelling buy right now. There may be some price volatility between now and the ADHD results in late Jan, but I suspect 2.30 will have been a tremendous entry point when the trial results start coming in, and rumors of a BP deal really heat up... Aiming4.